RecruitingNCT05381792

Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia

A Pilot Study to Assess Serial Gut Microbiome and a Panel of Bacterial Gene Markers (M3) Changes After Endoscopic Resection of Colorectal Advanced Neoplasia


Sponsor

Chinese University of Hong Kong

Enrollment

50 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators hypothesize that gut microbiome composition and the four bacterial gene markers (M3) show dynamic changes after endoscopic resection of advanced neoplasia, some key bacteria are associated with restoration of gut microbiome after endoscopic resection.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria3

  • Subjects require endoscopic resection (e.g. endoscopic mucosal resection or endoscopic submucosal dissection) for advanced adenoma or early-stage colorectal cancer;
  • Aged 18-90 years old;
  • Written informed consent obtained.

Exclusion Criteria4

  • Absolute contraindications to colonoscopy (e.g. perforation, intestinal obstruction, unstable cardiopulmonary status);
  • Contraindications to endoscopic resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets);
  • Known pregnancy or lactation;
  • Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above);

Interventions

DIAGNOSTIC_TESTBacterial gene markers test

Bacterial gene markers test using qPCR


Locations(1)

Prince of Wales Hospital

Shatin, New Territories, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05381792


Related Trials